Kellya Romano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kellya romano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kellya Romano Today - Breaking & Trending Today

Athira Pharma (NASDAQ:ATHA) Announces Earnings Results

Athira Pharma (NASDAQ:ATHA – Get Rating) issued its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.01), MarketWatch Earnings reports. NASDAQ ATHA opened at $8.28 on Friday. Athira Pharma has a 52-week low of $7.56 and a 52-week high of $23.64. The company […] ....

United States , Athira Pharma , Kellya Romano , Berenberg Bank , Life Insurance Co , Zacks Investment Research , Athira Pharma Company Profile Get Rating , Metlife Investment Management , Silverarc Capital Management , America Corp , Invesco Ltd , Athira Pharma Inc , Get Rating , Marketwatch Earnings , Investment Research , Director Kelly , Capital Management , Life Investment Management , Pharma Company Profile , Nasdaq Atha ,

Athira Pharma (NASDAQ:ATHA) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Athira Pharma (NASDAQ:ATHA – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.01), MarketWatch Earnings reports. Shares of Athira Pharma stock opened at $8.28 on Friday. Athira Pharma has a 1 year low of $7.56 and a […] ....

United States , Athira Pharma , Kellya Romano , Securities Exchange Commission , Berenberg Bank , Life Insurance Co , Zacks Investment Research , Athira Pharma Company Profile Get Rating , Metlife Investment Management , Silverarc Capital Management , America Corp , Invesco Ltd , Athira Pharma Inc , Get Rating , Marketwatch Earnings , Investment Research , Director Kelly , Exchange Commission , Capital Management , Life Investment Management , Pharma Company Profile , Nasdaq Atha ,

Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors


Share:
SEATTLE, Dec. 14, 2020 (GLOBE NEWSWIRE) Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Kelly A. Romano to its Board of Directors. Ms. Romano is the Founder and Chief Executive Officer of BlueRipple Capital, LLC, a consultancy firm for global technology companies.
As we expanded our Board, we sought a candidate who would help us best serve shareholders as we work towards making new treatments available for patients through the continued advancement of our Phase 2/3 clinical studies for ATH-1017 in Alzheimer s disease, said Leen Kawas, Ph.D., President and Chief Executive Officer at Athira. Kelly has a track record of operational success and an aptitude for understanding growing companies as we continue to drive the business forward. ....

Kellya Romano , Julie Rathbun , Darden School Of Management , Blueripple Capital , University Of New York At Buffalo , United Technologies Corp , Syracuse University , Dorman Products Inc , Exchange Commission , Athira Pharma Inc , Securities Exchange , University Of Virginia , Chief Executive Officer , Leen Kawas , Operating Partner , United Technologies , Intelligent Building Technologies , Dorman Products , Potter Electric , State University , New York , Northwestern University Kellogg School , Corporate Board Governance Executive Program , Darden School , Hepatocyte Growth Factor , Event Related Potential ,